SCHEMBL5193715

SCHEMBL5193715

Cc1ccc(-c2nc(C)c(C(=O)O)cc2S)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.55
▸ ALDH1A1 P00352 5/20 0.51
▸ MEN1 O00255 1/20 0.51
▸ KMT2A Q03164 1/20 0.51
▸ KDM4E B2RXH2 4/20 0.48
▸ GAA P10253 2/20 0.48
▸ HPGD P15428 2/20 0.48
▸ MAPT P10636 1/20 0.48
▸ MCL1 Q07820 1/20 0.46
▸ RAB9A P51151 3/20 0.43
▸ DHODH Q02127 3/20 0.43
▸ AKR1C2 P52895 1/20 0.42
▸ AKR1C1 Q04828 1/20 0.42
▸ RXFP1 Q9HBX9 1/20 0.42
▸ GABRP O00591 1/20 0.41
▸ GABRD O14764 1/20 0.41
▸ GABRA1 P14867 1/20 0.41
▸ GABRB1 P18505 1/20 0.41
▸ GABRG2 P18507 1/20 0.41
▸ GABRB3 P28472 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3498365 0.73 MEN1 (0.77) SMN1; SMN2ALDH1A1MEN1KMT2AKDM4E
SCHEMBL14252651 0.72 ALDH1A1 (0.54) SMN1; SMN2ALDH1A1MEN1KMT2AKDM4E
SCHEMBL16577109 0.71 MEN1 (0.55) SMN1; SMN2ALDH1A1MEN1KMT2AKDM4E
SCHEMBL17647519 0.71 SMN1; SMN2 (0.55) SMN1; SMN2ALDH1A1MEN1KMT2AKDM4E
SCHEMBL23574762 0.71 RXRB (0.49) SMN1; SMN2ALDH1A1MEN1KMT2AKDM4E
SCHEMBL70795 0.70 SMN1; SMN2 (0.65) SMN1; SMN2ALDH1A1MEN1KMT2AKDM4E
SCHEMBL9784598 0.70 ALDH1A1 (0.51) SMN1; SMN2ALDH1A1MEN1KMT2AKDM4E
SCHEMBL5193709 0.70 SMN1; SMN2 (0.54) SMN1; SMN2ALDH1A1MEN1KMT2AKDM4E
SCHEMBL23574229 0.70 AKR1C2 (0.48) SMN1; SMN2ALDH1A1MEN1KMT2AKDM4E
SCHEMBL4677848 0.70 ALDH1A1 (0.57) SMN1; SMN2ALDH1A1MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070232594-A1 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both KISSEI PHARMACEUTICAL CO., LTD. (JP) 2007-10-04 — — US disclosed
EP-1813603-A1 AROMATIC AMIDE DERIVATIVES, MEDICINAL COMPOSITIONS CONTAINING THE SAME, MEDICAL USES OF BOTH Kissei Pharmaceutical Co., Ltd. (JP) 2007-08-01 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232594-A1 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both AVPR2, AVPR1A, AVPR1B SMN1; SMN2 2669/4885ALDH1A1 1557/4885MEN1 1330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback